This is an old revision of the document!
Health Canada
History
COVID-19 crisis
On June 24, 2022, Health Canada appeared to delete nearly 2,000 “adverse events of special interest,” comprising 28.3% of their total collected of such reports to date.1) This move followed the publication of a pre-print study by Peter Doshi et al reviewing AESIs in the clinical trials by Pfizer and Moderna just one day prior.
On July 14, 2022, Health Canada authorized the use of the mRNA-1273 COVID-19 vaccine manufactured by Moderna for children 6 months to five years old.2) This marked the first such product authorized for that age group in Canada.
Divisions
Biologic and Radiopharmaceutical Drugs Directorate
The Biologic and Radiopharmaceutical Drugs Directorate (BRDD) regulates biological drugs (products made from living sources, including vaccines), radiopharmaceuticals (drugs that have radioactivity), and cells, tissues and organs for human use in Canada. The Directorate is also the regulatory authority responsible for the Assisted Human Reproduction (AHR) Act and its supporting regulations.3)
Affiliations
Staff
Health Canada's Board saw high turnover in the Ethics positions in 2020 and 2021.4)
1)
Tim Truth. (2022, September 4). Canada Govt DELETES Thousands Of Reported Adverse Events Of Special Interest Pertaining To Hearts, CNS & Autoimmune Disorders. Substack. https://archive.ph/N4qRl
2)
Health Canada. (2022, July 13). Health Canada authorizes use of Moderna COVID-19 vaccine in children 6 months to 5 years of age. Government of Canada. https://web.archive.org/web/20220716004905/https://www.canada.ca/en/health-canada/news/2022/07/health-canada-authorizes-use-of-moderna-covid-19-vaccine-in-children-6-months-to-5-years-of-age.html
3)
Health Canada. (2021, June 23). Biologic and Radiopharmaceutical Drugs Directorate. Government of Canada. https://archive.ph/DUsZi
4)
Health Canada Board Members History. Campfire Wiki; Operation Uplift. Retrieved April 4, 2022, from https://www.campfire.wiki/lib/exe/fetch.php?media=health_canada_board_members_history_1_.pdf